MSM Remain Most At-Risk Group For HIV In Beijing, Official Says Beijing's community of men who have sex with men are most at risk of contracting HIV, He Xiong, deputy director of the Beijing Center for Disease Control and Prevention, said Friday, China Daily reports. According to He, 5% of MSM in the city are HIV-positive.
Source: www.medicalnewstoday.comChina Sky One Medical, Inc. Announces 26 New Drugs In Clinical Trials China Sky One Medical, Inc. ("China Sky One Medical" or "the Company") (Amex: CSY), a leading fully integrated pharmaceutical company producing over-the-counter
drugs in the People's Republic of China ("PRC"), announced that it successfully developed 26 new
drugs that are currently in clinical trials. Heilongjiang Tianlong Pharmaceutical, Inc.
Source: www.medicalnewstoday.comTakeda Reigns Supreme Among Japanese Pharma Companies The Business Intelligence firm La MerieS.L. conducted an analysis to compare and rank Japanese pharmaceutical companiesregarding sales, net income, R&D expenses and biologics sales in the fiscal year 2007,ended March 31 2008. The study revealed the supremacy of Takeda Pharmaceutical Coover Japanese fellow pharma companies. Takeda not only posted record sales of US$12.5 bln in 2007, but also received top net income in absolute figures (US$ 3.3 bln) andas a percentage of sales (26.4 %).
Source: www.medicalnewstoday.com
# posted by Network @ 12:00 PM
